Physician Assistant · Fontana, CA
NPI
1811056526
Since 2006
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
9961 Sierra Ave
Fontana, CA, 92335
Phone (909) 427-3910
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$338K
735 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Renee M Echandi prescribed most often to Medicare patients was Retin-A (Tretinoin), with 93 prescriptions and refills. In total Renee M Echandi wrote 735 Medicare prescriptions that cost $338K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Retin-A Tretinoin | 93 | 95 | 39 | $2,671 |
| Ketoconazole Generic | 77 | 80 | 24 | $1,165 |
| Clobetasol Propionate Generic | 65 | 66 | 21 | $1,555 |
| Fluocinonide Generic | 43 | 48 | 25 | $829 |
| Hydrocortisone Generic | 39 | 41 | 23 | $520 |
| Triamcinolone Acetonide Generic | 39 | 59 | 24 | $1,074 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 38 | 48 | 20 | $1,892 |
| Fluorouracil Generic | 31 | 32 | 23 | $1,289 |
| Doxycycline Monohydrate Generic | 31 | 73 | 19 | $1,573 |
| Otezla Apremilast | 29 | 29 | Under 11 | $128K |
| Hydroxychloroquine Sulfate Generic | 22 | 70 | Under 11 | $890 |
| Cosentyx (2 Syringes) Secukinumab | 18 | 18 | Under 11 | $72K |
| Metronidazole Generic | 14 | 14 | Under 11 | $241 |
| Dupixent Pen Dupilumab | 14 | 14 | Under 11 | $54K |
| Clindamycin Phosphate Generic | 14 | 14 | Under 11 | $392 |
Brand drugs: 178 claims; generic drugs: 557 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Renee M Echandi were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.